Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$302,714,485
-$1,917,835 QoQ
Shares Held
1,596,427
+3.4% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#78
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Derivatives in AZN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$2,730,528
PutShares
14,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. AZN ranks #9 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,646,119 | $5,572,694,974 | |
| 2 | JNJ |
Johnson & Johnson
|
17,374,433 | $4,412,584,747 | |
| 3 | AMGN |
Amgen Inc
|
7,235,462 | $2,620,105,497 | |
| 4 | ABBV |
AbbVie Inc.
|
9,017,580 | $2,269,183,828 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,658,434 | $1,498,108,767 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
6,439,586 | $813,577,293 | |
| 7 | PFE |
Pfizer Inc
|
20,193,675 | $486,263,691 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,321,643 | $364,253,067 |
All Filings in AZN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $302,714,485 | 1,596,427 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $2,730,528 | 14,400 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $304,632,320 | 1,544,632 | Shares | Defined | 2026-05-11 | |
| 2026-03-31 | $2,366,640 | 12,000 | Put | Defined | 2026-05-11 | |
| 2026-03-31 | $19,327,560 | 98,000 | Call | Defined | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||